# Safety of Semaglutide

**Type:** Papers  
**Canonical URL:** https://scholariq.org/papers/safety-of-semaglutide/

## Facts

| Field | Value |
| --- | --- |
| Author Names | Mark M. Smits,Daniël H. van Raalte |
| Citations | 279 |
| DOI | 10.3389/fendo.2021.645563 |
| Fields | Biochemistry, Genetics and Molecular Biology,Medicine |
| Open Access | true |
| OA Status | gold |
| OA URL | https://www.frontiersin.org/articles/10.3389/fendo.2021.645563/pdf |
| OpenAlex ID | https://openalex.org/W3182424616 |
| PMID | 34305810 |
| Type | article |
| Year | 2021 |

## Paper authors

- [Daniël H. van Raalte](https://scholariq.org/researchers/daniel-h-van-raalte/)

## Paper journal

- [Frontiers in Endocrinology](https://scholariq.org/journals/frontiers-in-endocrinology/)

## Paper primary topic

- [Diabetes Treatment and Management](https://scholariq.org/topics/diabetes-treatment-and-management/)

## Paper topics

- [Diabetes Treatment and Management](https://scholariq.org/topics/diabetes-treatment-and-management/)
- [Metabolism, Diabetes, and Cancer](https://scholariq.org/topics/metabolism-diabetes-and-cancer/)
- [Chronic Lymphocytic Leukemia Research](https://scholariq.org/topics/chronic-lymphocytic-leukemia-research/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.